NLS Pharmaceutics AG (NLSP) — Strategic Asset Allocation Index
NLS Pharmaceutics AG (NLSP) has a Strategic Asset Allocation Index of 5.4% as of December 2021. Strategic assets (PP&E of $29.51K plus long-term investments of $-) total $29.51K, measured against net assets of $542.39K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
NLS Pharmaceutics AG Strategic Asset Allocation Index (2021–2021)
This chart shows how NLS Pharmaceutics AG's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the index stands at 5.4%, representing strategic assets of $29.51K against net assets of $542.39K USD. Explore NLS Pharmaceutics AG cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for NLS Pharmaceutics AG (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for NLS Pharmaceutics AG from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of NLS Pharmaceutics AG.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 5.4% | $29.51K | $29.51K | $- | $542.39K | — |